Aptamers

Group leader

Víctor Manuel González Muñoz

victor.m.gonzalez(ELIMINAR)@hrc.es

Tlf.: +34 91 336 81 73

Principal Investigator

  • Manuel Soto Álvarez
  • María Elena Martín Palma

Collaborating Staff

  • María Isabel Pérez Morgado
  • Silvia Sacristán López
  • María del Val Toledo Lobo
  • Celia Pinto Díez
  • Juan Manuel Gómez Hernández
  • Gerónimo Fernández Gómez-Chacón
  • Marta García Hernández
  • Miriam Barragán Usero
  • Ana María Salgado Figueroa
  • Raquel Ferreras Martín
  • Ignacio Iturrieta Zuazo
  • Mariana Fuentes-Quintana Miralles
  • Laura Herraiz Benitez
Imagen equipo

Group leader

Víctor Manuel González Muñoz

victor.m.gonzalez(ELIMINAR)@hrc.es

Tlf.: +34 91 336 81 73

Principal Investigator

  • Manuel Soto Álvarez
  • María Elena Martín Palma

Collaborating Staff

  • María Isabel Pérez Morgado
  • Silvia Sacristán López
  • María del Val Toledo Lobo
  • Celia Pinto Díez
  • Juan Manuel Gómez Hernández
  • Gerónimo Fernández Gómez-Chacón
  • Marta García Hernández
  • Miriam Barragán Usero
  • Ana María Salgado Figueroa
  • Raquel Ferreras Martín
  • Ignacio Iturrieta Zuazo
  • Mariana Fuentes-Quintana Miralles
  • Laura Herraiz Benitez

STRATEGIC OBJECTIVES

  • Development of detection systems based on aptamer technology that aim to improve the diagnosis and/or prognosis of different pathologies. Thus, enabling better patient care and cost savings for the health system.
  • Development of aptamers against targets involved in different pathologies (cancer, infections, etc.) for use in the design of drugs that will translate to new therapeutic options for patients.
  • Identification of new therapeutic targets in cancer.

RESEARCH LINES

  • Development of aptamers with a therapeutic potential.
  • Development of aptamer-based diagnostic systems.
  • Involvement of kinase Mnk1b in tumourigenesis

Location

 Aptamers Laboratory
 

Ramón y Cajal University Hospital
 1st floor right
 +34 91 336 83 88

Keywords

aptamer, diagnosis, MNK, therapy